ASIA unversity:Item 310904400/16716
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 94286/110023 (86%)
造訪人次 : 21713888      線上人數 : 426
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋


    請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/16716


    題名: Association between copy number variation of complement component C4 and Graves' disease.
    作者: 萬磊;Wan, Lei
    貢獻者: 生物科技學系
    日期: 2011-09
    上傳時間: 2012-11-23 09:16:13 (UTC+0)
    摘要: Background: Gene copy number of complement component C4, which varies among individuals, may determine
    the intrinsic strength of the classical complement pathway. Presuming a major role of complement as an effecter
    in peptide-mediated inflammation and phagocytosis, we hypothesized that C4 genetic diversity may partially
    explain the development of Graves’ disease (GD) and the variation in its outcomes.
    Methods: A case-control study including 624 patients with GD and 160 healthy individuals were enrolled. CNV of
    C4 isotypes (C4A and C4B) genes were performed by quantitative real-time polymerase chain reaction analysis.
    Statistical comparison and identification of CNV of total C4, C4 isotypes (C4A and C4B) and C4 polymorphisms were
    estimated according to the occurrence of GD and its associated clinical features.
    Results: Individuals with 4, 2, and 2 copies of C4, C4A and C4B genes, especially those with A2B2 polymorphism
    may associate with the development of GD (p = 0.001, OR = 10.994, 95% CI: 6.277-19.255; p = 0.008, OR = 1.732,
    95% CI: 1.190-2.520; p = 2.420 × 10-5, OR = 2.621, 95% CI: 1.791-3.835; and p = 1.395 × 10-4, OR = 2.671, 95% CI:
    1.761-4.052, respectively). Although the distribution of copy number for total C4, C4 isotypes as well as C4
    polymorphisms did not associate with the occurrence of goiter, nodular hyperplasia, GO and myxedema, <2 copies
    of C4A may associate with high risk toward vitiligo in patients with GD (p = 0.001, OR = 5.579, 95% CI:
    1.659-18.763).
    Conclusions: These results may be further estimated for its clinical application on GD and the vitiligo in patients
    with GD.
    關聯: JOURNAL OF BIOMEDICAL SCIENCE
    顯示於類別:[生物科技學系] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML326檢視/開啟


    在ASIAIR中所有的資料項目都受到原著作權保護.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋